308 related articles for article (PubMed ID: 33262762)
1. Tumor Infiltrating Effector Memory Antigen-Specific CD8
Principe N; Kidman J; Goh S; Tilsed CM; Fisher SA; Fear VS; Forbes CA; Zemek RM; Chopra A; Watson M; Dick IM; Boon L; Holt RA; Lake RA; Nowak AK; Lesterhuis WJ; McDonnell AM; Chee J
Front Immunol; 2020; 11():584423. PubMed ID: 33262762
[TBL] [Abstract][Full Text] [Related]
2. Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells.
Guilloux Y; Bai XF; Liu X; Zheng P; Liu Y
Cancer Res; 2001 Feb; 61(3):1107-12. PubMed ID: 11221840
[TBL] [Abstract][Full Text] [Related]
3. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
4. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.
Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF
Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163
[TBL] [Abstract][Full Text] [Related]
5. CD4
Ahrends T; Busselaar J; Severson TM; Bąbała N; de Vries E; Bovens A; Wessels L; van Leeuwen F; Borst J
Nat Commun; 2019 Dec; 10(1):5531. PubMed ID: 31797935
[TBL] [Abstract][Full Text] [Related]
6. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice.
Yuzefpolskiy Y; Baumann FM; Penny LA; Studzinski GP; Kalia V; Sarkar S
J Nutr; 2014 Dec; 144(12):2073-82. PubMed ID: 25320188
[TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
Front Immunol; 2020; 11():587014. PubMed ID: 33163002
[TBL] [Abstract][Full Text] [Related]
10. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
[TBL] [Abstract][Full Text] [Related]
11. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8
Li L; Jay SM; Wang Y; Wu SW; Xiao Z
Sci Rep; 2017 Oct; 7(1):13365. PubMed ID: 29042682
[TBL] [Abstract][Full Text] [Related]
12. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
13. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
14. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.
Kidman J; Zemek RM; Sidhom JW; Correa D; Principe N; Sheikh F; Fear VS; Forbes CA; Chopra A; Boon L; Zaitouny A; de Jong E; Holt RA; Jones M; Millward MJ; Lassmann T; Forrest ARR; Nowak AK; Watson M; Lake RA; Lesterhuis WJ; Chee J
Oncoimmunology; 2024; 13(1):2345859. PubMed ID: 38686178
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic Activity and Memory T Cell Subset Distribution of
Kuznetsova M; Lopatnikova J; Shevchenko J; Silkov A; Maksyutov A; Sennikov S
Front Immunol; 2019; 10():1017. PubMed ID: 31143180
[TBL] [Abstract][Full Text] [Related]
17. Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.
Muraoka D; Seo N; Hayashi T; Hyuga-Amaike C; Okamori K; Tawara I; Harada N; Shiku H
Oncotarget; 2017 May; 8(19):30766-30780. PubMed ID: 28430604
[TBL] [Abstract][Full Text] [Related]
18. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones.
Rohrer JW; Barsoum AL; Coggin JH
J Immunol; 2006 Mar; 176(5):2844-56. PubMed ID: 16493041
[TBL] [Abstract][Full Text] [Related]
19. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
20. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
